129 related articles for article (PubMed ID: 7546632)
1. Interactions between endothelial secretogogues.
Gryglewski RJ
Ann Med; 1995 Jun; 27(3):421-7. PubMed ID: 7546632
[TBL] [Abstract][Full Text] [Related]
2. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
[TBL] [Abstract][Full Text] [Related]
3. Endothelial nitric oxide, prostacyclin (PGI2) and tissue plasminogen activator (t-PA): alliance or neutrality?
Gryglewski RJ
Pol J Pharmacol; 1995; 47(5):467-72. PubMed ID: 8868142
[TBL] [Abstract][Full Text] [Related]
4. Interactions between endothelial mediators.
Gryglewski RJ
Pharmacol Toxicol; 1995 Jul; 77(1):1-9. PubMed ID: 8532605
[TBL] [Abstract][Full Text] [Related]
5. Bradykinin as a major endogenous regulator of endothelial function.
Gryglewski RJ; Uracz W; Chłopicki S; Marcinkiewicz E
Pediatr Pathol Mol Med; 2002; 21(3):279-90. PubMed ID: 12056503
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of acute myocardial infarction. Novel regulatory systems of bioactive substances in the vessel wall.
Kawai C
Circulation; 1994 Aug; 90(2):1033-43. PubMed ID: 8044917
[TBL] [Abstract][Full Text] [Related]
7. [Endothelial factors and thrombocyte function].
Schrör K
Z Kardiol; 1991; 80 Suppl 5():3-6. PubMed ID: 1776333
[TBL] [Abstract][Full Text] [Related]
8. Prostacyclin, nitric oxide, and atherosclerosis.
Gryglewski RJ; Chłopicki S; Swies J; Niezabitowski P
Ann N Y Acad Sci; 1995 Jan; 748():194-206; discussion 206-7. PubMed ID: 7695165
[TBL] [Abstract][Full Text] [Related]
9. NO is more important than PGI2 in maintaining low vascular tone in feto-placental vessels.
Chaudhuri G; Cuevas J; Buga GM; Ignarro LJ
Am J Physiol; 1993 Dec; 265(6 Pt 2):H2036-43. PubMed ID: 8285242
[TBL] [Abstract][Full Text] [Related]
10. Control of nitric oxide and prostacyclin synthesis in endothelial cells.
Busse R; Hecker M; Fleming I
Arzneimittelforschung; 1994 Mar; 44(3A):392-6. PubMed ID: 8185712
[TBL] [Abstract][Full Text] [Related]
11. Endothelial release of tissue-type plasminogen activator in the human forearm: role of nitric oxide.
Smith DT; Hoetzer GL; Greiner JJ; Stauffer BL; DeSouza CA
J Cardiovasc Pharmacol; 2003 Aug; 42(2):311-4. PubMed ID: 12883337
[TBL] [Abstract][Full Text] [Related]
12. Influence of endothelial mediators on the vascular smooth muscle and circulating platelets and blood cells.
Warner TD
Int Angiol; 1996 Jun; 15(2):93-9. PubMed ID: 8803631
[TBL] [Abstract][Full Text] [Related]
13. A major role for prostacyclin in nitric oxide-induced ocular vasorelaxation in the piglet.
Hardy P; Abran D; Hou X; Lahaie I; Peri KG; Asselin P; Varma DR; Chemtob S
Circ Res; 1998 Oct; 83(7):721-9. PubMed ID: 9758642
[TBL] [Abstract][Full Text] [Related]
14. The mechanisms and significance of the coupled release of endothelium-derived relaxing factor (EDRF) and prostacyclin (PGI2) from endothelial cells.
Hyslop S; de Nucci G
Wien Klin Wochenschr; 1991; 103(14):422-34. PubMed ID: 1926869
[TBL] [Abstract][Full Text] [Related]
15. In vitro studies of thromboresistance: the role of prostacyclin (PGI2) in platelet adhesion to cultured normal and virally transformed human vascular endothelial cells.
Curwen KD; Gimbrone MA; Handin RI
Lab Invest; 1980 Mar; 42(3):366-74. PubMed ID: 6244462
[TBL] [Abstract][Full Text] [Related]
16. A possible role of thromboxane A2 (TXA2) and prostacyclin (PGI2) in circulation.
Gryglewski RJ; Dembínska-Kieć A; Korbut R
Acta Biol Med Ger; 1978; 37(5-6):715-23. PubMed ID: 369254
[TBL] [Abstract][Full Text] [Related]
17. Thrombin-induced endothelium-dependent inhibition and direct activation of platelet-vessel wall interaction. Role of prostacyclin, nitric oxide, and thromboxane A2.
Yang Z; Arnet U; Bauer E; von Segesser L; Siebenmann R; Turina M; Lüscher TF
Circulation; 1994 May; 89(5):2266-72. PubMed ID: 8181152
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.
Salvemini D; Currie MG; Mollace V
J Clin Invest; 1996 Jun; 97(11):2562-8. PubMed ID: 8647949
[TBL] [Abstract][Full Text] [Related]
19. Reciprocal inhibition of nitric oxide and prostacyclin synthesis in human saphenous vein.
Barker JE; Bakhle YS; Anderson J; Treasure T; Piper PJ
Br J Pharmacol; 1996 Jun; 118(3):643-8. PubMed ID: 8762089
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy-dependent changes in cell signaling underlie changes in differential control of vasodilator production in uterine artery endothelial cells.
Bird IM; Sullivan JA; Di T; Cale JM; Zhang L; Zheng J; Magness RR
Endocrinology; 2000 Mar; 141(3):1107-17. PubMed ID: 10698187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]